351 related articles for article (PubMed ID: 29458840)
1. Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis.
Matamala JM; Arias-Carrasco R; Sanchez C; Uhrig M; Bargsted L; Matus S; Maracaja-Coutinho V; Abarzua S; van Zundert B; Verdugo R; Manque P; Hetz C
Neurobiol Aging; 2018 Apr; 64():123-138. PubMed ID: 29458840
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the causal association between microRNAs and amyotrophic lateral sclerosis.
Zhu Y; Li M; He Z; Pang X; Du R; Yu W; Zhang J; Bai J; Wang J; Huang X
Neurol Sci; 2023 Oct; 44(10):3567-3575. PubMed ID: 37261630
[TBL] [Abstract][Full Text] [Related]
3. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients.
Saucier D; Wajnberg G; Roy J; Beauregard AP; Chacko S; Crapoulet N; Fournier S; Ghosh A; Lewis SM; Marrero A; O'Connell C; Ouellette RJ; Morin PJ
Brain Res; 2019 Apr; 1708():100-108. PubMed ID: 30552897
[TBL] [Abstract][Full Text] [Related]
4. Assessment of diagnostic potential of some circulating microRNAs in Amyotrophic Lateral Sclerosis Patients, an Egyptian study.
Soliman R; Mousa NO; Rashed HR; Moustafa RR; Hamdi N; Osman A; Fahmy N
Clin Neurol Neurosurg; 2021 Sep; 208():106883. PubMed ID: 34454204
[TBL] [Abstract][Full Text] [Related]
5. Identification of let-7f and miR-338 as plasma-based biomarkers for sporadic amyotrophic lateral sclerosis using meta-analysis and empirical validation.
Daneshafrooz N; Joghataei MT; Mehdizadeh M; Alavi A; Barati M; Panahi B; Teimourian S; Zamani B
Sci Rep; 2022 Jan; 12(1):1373. PubMed ID: 35082326
[TBL] [Abstract][Full Text] [Related]
6. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
[TBL] [Abstract][Full Text] [Related]
7. Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS).
Waller R; Goodall EF; Milo M; Cooper-Knock J; Da Costa M; Hobson E; Kazoka M; Wollff H; Heath PR; Shaw PJ; Kirby J
Neurobiol Aging; 2017 Jul; 55():123-131. PubMed ID: 28454844
[TBL] [Abstract][Full Text] [Related]
8. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis.
Takahashi I; Hama Y; Matsushima M; Hirotani M; Kano T; Hohzen H; Yabe I; Utsumi J; Sasaki H
Mol Brain; 2015 Oct; 8(1):67. PubMed ID: 26497046
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
Vistbakka J; Elovaara I; Lehtimäki T; Hagman S
Mult Scler; 2017 Mar; 23(3):403-412. PubMed ID: 27246141
[TBL] [Abstract][Full Text] [Related]
10. Signature of miRNAs derived from the circulating exosomes of patients with amyotrophic lateral sclerosis.
Cheng YF; Gu XJ; Yang TM; Wei QQ; Cao B; Zhang Y; Shang HF; Chen YP
Front Aging Neurosci; 2023; 15():1106497. PubMed ID: 36845651
[TBL] [Abstract][Full Text] [Related]
11. Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis.
Raheja R; Regev K; Healy BC; Mazzola MA; Beynon V; Von Glehn F; Paul A; Diaz-Cruz C; Gholipour T; Glanz BI; Kivisakk P; Chitnis T; Weiner HL; Berry JD; Gandhi R
Muscle Nerve; 2018 Aug; 58(2):261-269. PubMed ID: 29466830
[TBL] [Abstract][Full Text] [Related]
12. The Role of MicroRNAs in Patients with Amyotrophic Lateral Sclerosis.
Dardiotis E; Aloizou AM; Siokas V; Patrinos GP; Deretzi G; Mitsias P; Aschner M; Tsatsakis A
J Mol Neurosci; 2018 Dec; 66(4):617-628. PubMed ID: 30415446
[TBL] [Abstract][Full Text] [Related]
13. Serum microRNAs in sporadic amyotrophic lateral sclerosis.
Freischmidt A; Müller K; Zondler L; Weydt P; Mayer B; von Arnim CA; Hübers A; Dorst J; Otto M; Holzmann K; Ludolph AC; Danzer KM; Weishaupt JH
Neurobiol Aging; 2015 Sep; 36(9):2660.e15-20. PubMed ID: 26142125
[TBL] [Abstract][Full Text] [Related]
14. Differential Expression of MicroRNAs and Predicted Drug Target in Amyotrophic Lateral Sclerosis.
Patel RB; Bajpai AK; Thirumurugan K
J Mol Neurosci; 2023 Jun; 73(6):375-390. PubMed ID: 37249795
[TBL] [Abstract][Full Text] [Related]
15. Circulating miRNA Expression Profiling and Target Prediction in Patients Receiving Dexmedetomidine.
Yang X; Chen H; Chen Y; Birnbaum Y; Liang R; Ye Y; Qian J
Cell Physiol Biochem; 2018; 50(2):552-568. PubMed ID: 30308506
[TBL] [Abstract][Full Text] [Related]
16. Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration.
ElShelmani H; Brennan I; Kelly DJ; Keegan D
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830203
[TBL] [Abstract][Full Text] [Related]
17. Characterization of micro-RNA Profile in the Blood of Patients with Marfan's Syndrome.
Abu-Halima M; Ludwig N; Rädle-Hurst T; Keller A; Motsch L; Marsollek I; El Rahman MA; Abdul-Khaliq H; Meese E
Thorac Cardiovasc Surg; 2018 Jan; 66(1):116-124. PubMed ID: 28679133
[TBL] [Abstract][Full Text] [Related]
18. Wide-Ranging Analysis of MicroRNA Profiles in Sporadic Amyotrophic Lateral Sclerosis Using Next-Generation Sequencing.
De Felice B; Manfellotto F; Fiorentino G; Annunziata A; Biffali E; Pannone R; Federico A
Front Genet; 2018; 9():310. PubMed ID: 30154826
[TBL] [Abstract][Full Text] [Related]
19. Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis.
Freischmidt A; Müller K; Ludolph AC; Weishaupt JH
Acta Neuropathol Commun; 2013 Jul; 1():42. PubMed ID: 24252274
[TBL] [Abstract][Full Text] [Related]
20. Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS.
Varcianna A; Myszczynska MA; Castelli LM; O'Neill B; Kim Y; Talbot J; Nyberg S; Nyamali I; Heath PR; Stopford MJ; Hautbergue GM; Ferraiuolo L
EBioMedicine; 2019 Feb; 40():626-635. PubMed ID: 30711519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
